Follow us on LinkedIn, Instagram, Facebook, YouTube and Twitter
Sydney, April 25: A new iron supplement may help women reduce the side effects caused by iron deficiency during pregnancy.
Iron deficiency is a common condition in pregnancy with up to two-thirds of women needing supplements.
If left unchecked, iron deficiency among pregnant women can lead to serious complications such as pre-eclampsia, premature birth, low birth weight babies, and long-term cognitive impairment in the infant.
QIMR Berghofer PhD student Sheridan Helman, who led the study, said the existing iron sulfate treatments can cause such severe side effects that up to half of all pregnant women stop taking them.
“We found iron hydroxide adipate tartrate (IHAT) is a promising alternative to treat iron deficiency because it was just as safe and effective at boosting iron levels in pregnant mice as existing treatments, but with fewer adverse side effects,” Helman said.
“If you speak with pregnant women who’ve had to take traditional supplements, they will tell you the side effects can be awful.
“Our goal is to help find a better alternative to treat their iron deficiency and anaemia without discomfort, ensuring the best health outcome for themselves and their babies.”
Side effects from taking large doses of iron supplements include abdominal pain, nausea, constipation, and diarrhoea.
There is also growing evidence it negatively impacts a patient’s gut microbiome which creates other health issues.
The Head of QIMR Berghofer’s Molecular Nutrition Laboratory, Associate Professor David Frazer said the next step is trials in pregnant women.
“We have the data showing IHAT is safe and effective in human adults and children, and in pregnant mice, so our next goal is to see if we can reproduce these results in pregnant women.
“We’re working through the ethical issues involved to move to this next phase,” Frazer said.
“The IHAT treatment is exciting because we’ve found there are fewer side effects, less stress on the body, and less damage to the microbiome of the gut.”
The findings of the study could have broader benefits with at least 10 per cent of Australian women likely to be deficient in iron.
The IHAT supplement was co-invented by Cambridge University’s Professor Jonathan Powell who collaborated with QIMR Berghofer’s Molecular Nutrition Laboratory to test its efficacy.
Pharmaceutical company Nemysis owns the right to develop the drug.
Editor’s Note: You can now download our app on the Google Play Store or the Apple Store, or write your next best-selling novel with our sister app Toolis, available on the Apple Store and Google Play Store or purchase something from us at www.tapiroo.com, yayaezzy.com or at lazybumskincare.com.au. Also, check out our rate card and media kit here if you would like to advertise with us on this website. Thank you!
Like What You Read?
Howdy! Thanks for dropping by and reading our stuff. DailyStraits.com is an independent website that covers all things business and entrepreneurship related. If you like what you read, a little donation from your good self will go a long way in helping us run this site successfully. Thank you!
Welcome to dailystraits.com.Please send all interview requests and press releases to firstname.lastname@example.org. Thank you!